608 
Evaluation of Relationship between CD4 and Total Lymphocyte Count in Children with HIV
Jason Brophy*, E Atenafu, S Read, D Stephens, J Beyene, and A Bitnun
Hosp for Sick Children, Toronto, Canada
Background: CD4 counts and viral loads are integral
components of HIV disease monitoring, allowing decision-making regarding
treatment initiation and changes. However, these technologies are costly and
require lab equipment and expertise that is not available in many resource-poor
settings. There is a paucity of data regarding the correlation between CD4 and total
lymphocyte count (TLC) in HIV-infected children. However, based on limited
data, the World Health Organization (WHO) has made recommendations regarding
TLC cut-offs for initiation of ART for children. Using our database of children
with HIV, we attempted to further evaluate the relationship between CD4 and TLC
in order to inform current practice in HIV disease management in
resource-limited settings.
Methods: We retrospectively reviewed clinical and
laboratory data of all HIV-infected children seen at The Hospital for Sick
Children from 1995 to 2005. Using paired CD4/TLC data for each patient, we
determined the degree of relatedness between these 2 measures, taking into
account potential confounders such as age, ART, and race. We evaluated the
reliability of the TLC cut-offs suggested in the WHO 2006 guidelines on pediatric
ART in resource limited settings.
Results: Data for 126 patients aged 2 weeks to 18
years were collected, including information from 3650 visits. There was no
significant difference in TLC count between children of black race and children
of other races. In regression analysis adjusted for age, race, and ART, TLC and
total CD4 count were highly correlated (p <0.0001) as were change in
TLC and change in CD4 count (p <0.0001). A mean change in TLC of 2.0
x106 cells/L (SE 0.038) was observed for every 1 cell/mm3
change in CD4 count. In evaluating the cut-offs proposed by WHO, the TLC
cut-off for each age group (<1, 1 to 3, 3 to 5, 5 to 8, and >8 years) predicted
the appropriate CD4 cut-off in 80%, 88%, 83%, 84%, and 89% of the time,
respectively.
Conclusions: TLC is a good predictor of CD4 count,
though the cut-offs for treatment proposed by the WHO may be suboptimal.
|